| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regenxbio Inc. (RGNX) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. RGNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | $5.21M | - | |
| CEO | 338.1K | $3.55M | - | |
| Other | 215.4K | $2.26M | - | |
| Other | 64.8K | $680.5K | - | |
| CFO | 39.6K | $416.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2024 | Simpson Curran66 | Chief Executive Officer | Sell | 100 | $15.00 | $1,500.00 | - | -33.6% | -38.5% | |
| Jul 29, 2024 | Simpson Curran66 | Chief Executive Officer | Sell | 9,648 | $15.04 | $145,105.92 | -5.4% | -34.6% | -41.4% | |
| Jul 29, 2024 | Karabelas Argeris N73 | Director | Sale+OE | 11,000 | $15.05 | $165,495.00 | -49.4% | -34.6% | -41.4% | |
| Jul 25, 2024 | Mills Kenneth T.81 | Director | Sale+OE | 27,590 | $13.88 | $382,934.01 | -3.3% | -32.3% | -37.7% | |
| Jul 17, 2024 | Mills Kenneth T.81 | Director | Sale+OE | 2,410 | $13.77 | $33,191.88 | -0.3% | -22.4% | -34.6% | |
| Jul 1, 2024 | Karabelas Argeris N73 | Director | Sale+OE | 10,000 | $11.27 | $112,691.00 | -47.0% | -5.2% | -25.7% | |
| May 14, 2024 | Mills Kenneth T.81 | President And CEO | Sale+OE | 15,000 | $15.81 | $237,222.00 | -3.5% | -24.4% | -47.3% | |
| Apr 15, 2024 | Mills Kenneth T.81 | President And CEO | Sale+OE | 15,000 | $18.19 | $272,871.00 | -3.5% | -28.6% | -63.7% | |
| Mar 14, 2024 | Mills Kenneth T.81 | President And CEO | Sale+OE | 15,000 | $21.86 | $327,942.00 | -3.5% | -39.8% | -69.2% | |
| Mar 5, 2024 | Pakola Steve70 | Chief Medical Officer | Sale+OE | 12,878 | $28.36 | $365,220.08 | -10.7% | -40.0% | -74.6% |